Theratechnologies Secures US Patent for its Novel Peptide TH1173
Theratechnologies Inc. (TSX: TH)(NASDAQ: THER) today reported that the US Patent and Trademark Office (USPTO) has granted a patent (US Patent No. 8,361,964) for its second generation growth-hormone releasing factor (GRF) peptide, TH1173, providin ...